Worse progression of COVID-19 in men: Is testosterone a key factor?
COVID-19
gender
male hypogonadism
obesity
testosterone
thrombosis
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
08
05
2020
revised:
22
05
2020
accepted:
03
06
2020
pubmed:
12
6
2020
medline:
4
2
2021
entrez:
12
6
2020
Statut:
ppublish
Résumé
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) disease 2019 (COVID-19) seems to have a worse clinical course among infected men compared with women, thus highlighting concerns about gender predisposition to serious prognosis. Therefore, androgens, particularly testosterone (T), could be suspected as playing a critical role in driving this excess of risk. However, gonadal function in critically ill men is actually unknown, mainly because serum T concentration is not routinely measured in clinical practice, even more in this clinical context. To overview on possible mechanisms by which serum T levels could affect the progression of COVID-19 in men. Authors searched PubMed/MEDLINE, Web of Science, EMBASE, Cochrane Library, Google, and institutional websites for medical subject headings terms and free text words referred to "SARS-CoV-2," "COVID-19," "testosterone," "male hypogonadism," "gender" "immune system," "obesity," "thrombosis" until May 19th 2020. T, co-regulating the expression of angiotensin-converting enzyme 2 and transmembrane protease serine 2 in host cells, may facilitate SARS-CoV-2 internalization. Instead, low serum T levels may predispose to endothelial dysfunction, thrombosis and defective immune response, leading to both impaired viral clearance and systemic inflammation. Obesity, one of the leading causes of severe prognosis in infected patients, is strictly associated with functional hypogonadism, and may consistently strengthen the aforementioned alterations, ultimately predisposing to serious respiratory and systemic consequences. T in comparison to estrogen may predispose men to a widespread COVID-19 infection. Low serum levels of T, which should be supposed to characterize the hormonal milieu in seriously ill individuals, may predispose men, especially elderly men, to poor prognosis or death. Further studies are needed to confirm these pathophysiological assumptions and to promptly identify adequate therapeutic strategies.
Sections du résumé
BACKGROUND
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) disease 2019 (COVID-19) seems to have a worse clinical course among infected men compared with women, thus highlighting concerns about gender predisposition to serious prognosis. Therefore, androgens, particularly testosterone (T), could be suspected as playing a critical role in driving this excess of risk. However, gonadal function in critically ill men is actually unknown, mainly because serum T concentration is not routinely measured in clinical practice, even more in this clinical context.
OBJECTIVE
To overview on possible mechanisms by which serum T levels could affect the progression of COVID-19 in men.
METHODS
Authors searched PubMed/MEDLINE, Web of Science, EMBASE, Cochrane Library, Google, and institutional websites for medical subject headings terms and free text words referred to "SARS-CoV-2," "COVID-19," "testosterone," "male hypogonadism," "gender" "immune system," "obesity," "thrombosis" until May 19th 2020.
RESULTS
T, co-regulating the expression of angiotensin-converting enzyme 2 and transmembrane protease serine 2 in host cells, may facilitate SARS-CoV-2 internalization. Instead, low serum T levels may predispose to endothelial dysfunction, thrombosis and defective immune response, leading to both impaired viral clearance and systemic inflammation. Obesity, one of the leading causes of severe prognosis in infected patients, is strictly associated with functional hypogonadism, and may consistently strengthen the aforementioned alterations, ultimately predisposing to serious respiratory and systemic consequences.
DISCUSSION AND CONCLUSION
T in comparison to estrogen may predispose men to a widespread COVID-19 infection. Low serum levels of T, which should be supposed to characterize the hormonal milieu in seriously ill individuals, may predispose men, especially elderly men, to poor prognosis or death. Further studies are needed to confirm these pathophysiological assumptions and to promptly identify adequate therapeutic strategies.
Identifiants
pubmed: 32524732
doi: 10.1111/andr.12836
pmc: PMC7307026
doi:
Substances chimiques
Receptors, Virus
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
53-64Informations de copyright
© 2020 American Society of Andrology and European Academy of Andrology.
Références
Diabetes. 2010 Dec;59(12):2994-6
pubmed: 21115782
Amino Acids. 2015 Apr;47(4):693-705
pubmed: 25534429
Cell Mol Immunol. 2020 Apr 7;:
pubmed: 32265513
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Blood. 2000 Apr 1;95(7):2289-96
pubmed: 10733498
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
Aging (Albany NY). 2018 May 2;10(5):902-929
pubmed: 29723157
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
Lancet. 2020 May 9;395(10235):1517-1520
pubmed: 32311318
Obes Rev. 2020 Jun;21(6):e13034
pubmed: 32281287
Eur Endocrinol. 2019 Aug;15(2):83-90
pubmed: 31616498
Kidney Int Rep. 2017 Aug 04;2(6):1160-1168
pubmed: 29270524
Biol Rev Camb Philos Soc. 2017 Feb;92(1):551-571
pubmed: 26800512
BMJ Open. 2013 Aug 13;3(8):
pubmed: 23943774
J Infect Dis. 2020 May 11;221(11):1762-1769
pubmed: 32227123
J Androl. 2009 Jan-Feb;30(1):10-22
pubmed: 18641413
Gynecol Endocrinol. 2005 May;20(5):249-57
pubmed: 16019369
Annu Rev Immunol. 1995;13:307-38
pubmed: 7612226
Acad Radiol. 2020 May;27(5):752
pubmed: 32273135
Steroids. 1990 Aug;55(8):330-52
pubmed: 2237942
Am J Hematol. 2020 Jul;95(7):E156-E158
pubmed: 32267008
Blood. 2012 Jan 12;119(2):454-64
pubmed: 22096248
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Life Sci. 2006 Apr 4;78(19):2166-71
pubmed: 16303146
J Clin Endocrinol Metab. 1993 Dec;77(6):1610-5
pubmed: 8263149
Gend Med. 2012 Dec;9(6):390-401
pubmed: 23164528
Metabolism. 2020 Jul;108:154252
pubmed: 32353355
Front Immunol. 2017 Jul 26;8:896
pubmed: 28798751
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Am J Physiol Endocrinol Metab. 2017 Oct 1;313(4):E450-E462
pubmed: 28655716
Eur J Endocrinol. 2009 Sep;161(3):435-42
pubmed: 19542243
FEBS J. 2008 Nov;275(22):5458-78
pubmed: 18959737
Cochrane Database Syst Rev. 2020 May 14;5:CD013600
pubmed: 32406927
Cells. 2020 Apr 09;9(4):
pubmed: 32283711
Diabetes Res Clin Pract. 2020 Apr;162:108132
pubmed: 32234504
Cell Death Dis. 2019 Mar 8;10(3):233
pubmed: 30850582
Angiology. 2018 Aug;69(7):564-567
pubmed: 28954526
Horm Res. 2000;54(5-6):294-5
pubmed: 11595820
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Arch Med Res. 2020 May;51(4):345-346
pubmed: 32279908
Circulation. 2020 Jul 7;142(1):4-6
pubmed: 32320270
Cardiovasc Res. 2019 Feb 1;115(2):453-462
pubmed: 30052805
Endocrinology. 2004 Oct;145(10):4703-11
pubmed: 15231706
Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1383-7
pubmed: 8911277
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Curr Top Microbiol Immunol. 2014;380:69-92
pubmed: 25004814
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Cardiovasc Diabetol. 2006 Feb 23;5:4
pubmed: 16504104
J Immunol. 2009 May 1;182(9):5488-97
pubmed: 19380797
Atherosclerosis. 1988 May;71(1):71-6
pubmed: 3377881
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Eur J Microbiol Immunol (Bp). 2015 Mar;5(1):14-24
pubmed: 25883791
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
J Thromb Thrombolysis. 2020 Jul;50(1):229-232
pubmed: 32306290
Br J Haematol. 2020 Jun;189(5):846-847
pubmed: 32304577
Andrology. 2015 Mar;3(2):298-308
pubmed: 25704864
World J Mens Health. 2013 Aug;31(2):136-40
pubmed: 24044108
Arch Intern Med. 2008 Dec 8;168(22):2405-14
pubmed: 19064822
JAMA Intern Med. 2020 Jul 1;180(7):927-928
pubmed: 32259190
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Clin Endocrinol Metab. 1994 Feb;78(2):292-8
pubmed: 8106614
J Lab Clin Med. 1993 Oct;122(4):412-20
pubmed: 8228555
Sci Rep. 2018 May 9;8(1):7392
pubmed: 29743556
J Immunol. 2017 Mar 1;198(5):1782-1790
pubmed: 28223406
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
J Endocrinol. 2013 May 07;217(3):R47-71
pubmed: 23549841
Horm Behav. 2017 Feb;88:95-105
pubmed: 27956226
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
Andrology. 2021 Jan;9(1):53-64
pubmed: 32524732
J Thromb Haemost. 2020 Jun;18(6):1469-1472
pubmed: 32302435
J Exp Med. 2015 Jun 29;212(7):1011-20
pubmed: 26077720
Trends Immunol. 2016 Dec;37(12):866-876
pubmed: 27720177
Front Immunol. 2016 Dec 08;7:495
pubmed: 28008329
Nat Med. 2005 Aug;11(8):821-2
pubmed: 16079870
Transplant Proc. 2012 May;44(4):1067-9
pubmed: 22564626
J Am Geriatr Soc. 2005 Sep;53(9):1565-9
pubmed: 16137288
Eur Heart J. 2016 Jan 1;37(1):24-34
pubmed: 26530104
Platelets. 2019;30(4):473-479
pubmed: 29737900
Endocr Metab Immune Disord Drug Targets. 2020;20(6):807-811
pubmed: 32338224
Neurochem Res. 2019 Jun;44(6):1323-1329
pubmed: 30443713
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):92-9
pubmed: 23369141
Nature. 2020 Jan;577(7790):416-420
pubmed: 31875850
Mol Med Rep. 2017 Jun;15(6):3905-3911
pubmed: 28440441
J Clin Med. 2020 Feb 20;9(2):
pubmed: 32093211
Mayo Clin Proc. 2018 Jan;93(1):83-100
pubmed: 29275030
Endocr Metab Immune Disord Drug Targets. 2020;20(9):1391-1411
pubmed: 32250234
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Eur J Endocrinol. 2000 Jul;143(1):31-6
pubmed: 10870028
J Clin Invest. 2002 Jun;109(12):1625-33
pubmed: 12070310
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Biochem J. 2005 Jun 15;388(Pt 3):967-72
pubmed: 15537383
Nat Biotechnol. 2020 Jun;38(6):655-658
pubmed: 32358594
J Diabetes Res. 2018 Nov 8;2018:7457269
pubmed: 30533447
J Clin Endocrinol Metab. 2006 Feb;91(2):546-54
pubmed: 16317058
Exp Physiol. 2008 May;93(5):549-56
pubmed: 18223023
J Infect Dis. 2015 Oct 15;212(8):1214-21
pubmed: 25904605
Aging Male. 2019 Jun;22(2):129-140
pubmed: 29925283
J Endocrinol. 2015 Mar;224(3):R131-7
pubmed: 25563353
Endocr Rev. 2003 Jun;24(3):313-40
pubmed: 12788802
Am J Cardiol. 2019 Jun 1;123(11):1757-1764
pubmed: 30928032
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Circulation. 1995 Jun 1;91(11):2742-7
pubmed: 7758179
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
J Clin Endocrinol Metab. 2004 Jul;89(7):3313-8
pubmed: 15240608
Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250
pubmed: 32247212
Sci Rep. 2019 Jul 22;9(1):10589
pubmed: 31332232
Circulation. 2007 Mar 13;115(10):1285-95
pubmed: 17353456
J Leukoc Biol. 2000 Jan;67(1):40-5
pubmed: 10647996
J Clin Endocrinol Metab. 1994 Oct;79(4):997-1000
pubmed: 7962311
Front Horm Res. 2009;37:91-107
pubmed: 19011291
Obesity (Silver Spring). 2020 Jun;28(6):1007
pubmed: 32294322
Obesity (Silver Spring). 2020 May;28(5):847
pubmed: 32237212
Prev Med. 2015 Nov;80:89-100
pubmed: 26123717
Neurology. 2007 Feb 20;68(8):563-8
pubmed: 17310026
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Am Heart J. 1988 Jul;116(1 Pt 2):266-72
pubmed: 3394638
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Crit Care Resusc. 2020 Apr 15;22(2):95-97
pubmed: 32294809
J Thromb Haemost. 2020 Jul;18(7):1548-1555
pubmed: 32329246
Biol Sex Differ. 2010 Nov 05;1(1):6
pubmed: 21208466
Vasc Health Risk Manag. 2005;1(3):183-98
pubmed: 17319104
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Obesity (Silver Spring). 2020 Jun;28(6):1005
pubmed: 32237206
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
J Immunol. 2013 Mar 15;190(6):2650-8
pubmed: 23396945
Asian J Androl. 2018 Mar-Apr;20(2):120-130
pubmed: 29442075
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Circulation. 2007 Dec 4;116(23):2694-701
pubmed: 18040028
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):51-7
pubmed: 23369137
JAMA Netw Open. 2020 Apr 1;3(4):e205619
pubmed: 32275319
J Clin Endocrinol Metab. 2002 Aug;87(8):3632-9
pubmed: 12161487
EBioMedicine. 2020 May;55:102768
pubmed: 32344202
PLoS One. 2016 Apr 28;11(4):e0153751
pubmed: 27124181
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):198-204
pubmed: 27364394
Obesity (Silver Spring). 2020 Jul;28(7):1176-1177
pubmed: 32299148
Redox Biol. 2020 Apr;31:101482
pubmed: 32197947
Blood Coagul Fibrinolysis. 2015 Oct;26(7):811-5
pubmed: 26192112
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Mol Cell Endocrinol. 2015 Sep 5;412:123-30
pubmed: 26054748
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4888-93
pubmed: 9560198
Hormones (Athens). 2015 Oct-Dec;14(4):569-78
pubmed: 26732155
J Endocrinol Invest. 2002 Nov;25(10):899-904
pubmed: 12508953
Eur J Endocrinol. 2004 Jan;150(1):65-71
pubmed: 14713281
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331343
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Rev Nephrol. 2018 May;14(5):325-336
pubmed: 29578208
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
Front Horm Res. 2019;53:18-32
pubmed: 31499499
J Endocrinol Invest. 2014 Feb;37(2):135-41
pubmed: 24497212
Hypertension. 2008 Nov;52(5):818-27
pubmed: 18852389
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Expert Rev Respir Med. 2018 Sep;12(9):755-767
pubmed: 30056777
Endocrinology. 2001 Nov;142(11):4589-94
pubmed: 11606422
J Med Virol. 2020 Oct;92(10):2050-2054
pubmed: 32383183
J Immunol. 2014 Dec 1;193(11):5444-52
pubmed: 25339659
J Immunol. 2018 Oct 1;201(7):1843-1854
pubmed: 30127088
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Clin Appl Thromb Hemost. 2014 Jan;20(1):22-30
pubmed: 23615294
Emerg Infect Dis. 2020 Jul;26(7):1626-1628
pubmed: 32228809
J Clin Endocrinol Metab. 2008 Jan;93(1):68-75
pubmed: 17911176
J Korean Med Sci. 2020 Mar 16;35(10):e112
pubmed: 32174069
Front Endocrinol (Lausanne). 2014 Jul 07;5:106
pubmed: 25071722
PLoS One. 2013 Apr 24;8(4):e61598
pubmed: 23637864
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342
pubmed: 32202240
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098
pubmed: 32501810